# SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE
> **ANDA216885** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON PHARMACEUTICAL INC · Approved 2025-03-13
## Drug
- **FDA Application Number:** ANDA216885
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE
- **Generic name:** Metformin Hydrochloride, Sitagliptin Phosphate
- **Active ingredients:** METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE
- **Dosage form:** TABLET
- **Route:** FILM COATED
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** PRINSTON PHARMACEUTICAL INC
- **First approval:** 2025-03-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216885)
---
*AI Analytics · CC0 1.0*